The discovery of novel AKT inhibitor (4-(purin-6-yl)piperazin-1-yl)(benzofuran-2-yl)methanone for treatment of myeloid neoplasms: Computer modelling, synthesis and biological activity
Authors: Konstantin N. Semenov, Elena V. Pimenova, Vladislav A. Sokolov et al.
Publication: Journal of Molecular Liquids
Published: May 1, 2026
Source: Crossref